Multiple Sclerosis Drug Shows Promise for Enhancing Working Memory

Fampridine may improve cognitive function in individuals with initially poor working memory, according to new research.

Fampridine, a drug used to aid walking in multiple sclerosis patients, may enhance working memory in those with cognitive impairments.
The study found significant improvements in individuals with poor baseline working memory after three days of fampridine treatment.
Researchers observed increased brain excitability, suggesting faster and more efficient neural communication.
The potential for fampridine to treat cognitive deficits in conditions like schizophrenia and depression is being further explored.
The study was a randomized, double-blind trial involving 43 healthy adults and highlights the need for personalized cognitive therapies.